These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 21505091

  • 1. Fluorothalidomide: a characterization of maternal and developmental toxicity in rabbits and mice.
    Lee CJ, Shibata N, Wiley MJ, Wells PG.
    Toxicol Sci; 2011 Jul; 122(1):157-69. PubMed ID: 21505091
    [Abstract] [Full Text] [Related]

  • 2. Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.
    Lee CJ, Gonçalves LL, Wells PG.
    Toxicol Sci; 2011 Jul; 122(1):146-56. PubMed ID: 21505090
    [Abstract] [Full Text] [Related]

  • 3. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
    Lee CJ, Gonçalves LL, Wells PG.
    FASEB J; 2011 Jul; 25(7):2468-83. PubMed ID: 21502285
    [Abstract] [Full Text] [Related]

  • 4. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F, Pino M, DeLise B, Guittin P, Barbellion S, Brunel P, Potdevin S, Bergmann B, Hofmann T, Lerman S, Clark RL.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [Abstract] [Full Text] [Related]

  • 5. Effects of thalidomide on developmental, peri- and postnatal function in female New Zealand white rabbits and offspring.
    Teo SK, Denny KH, Stirling DI, Thomas SD, Morseth S, Hoberman AM.
    Toxicol Sci; 2004 Oct; 81(2):379-89. PubMed ID: 15229368
    [Abstract] [Full Text] [Related]

  • 6. Never-ending tales of the mode of the teratogenic action of thalidomide.
    Neubert D.
    Teratog Carcinog Mutagen; 1997 Oct; 17(1):i-ii. PubMed ID: 9249924
    [No Abstract] [Full Text] [Related]

  • 7. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS, Brown-Woodman PD, Ritchie HE.
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [Abstract] [Full Text] [Related]

  • 8. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
    Kochhar DM, Jiang H, Penner JD, Heyman RA.
    Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
    [Abstract] [Full Text] [Related]

  • 9. Embryo-fetal exposure and developmental outcome of thalidomide following oral and intravaginal administration to pregnant rabbits.
    Hui JY, Hoffmann M, Kumar G.
    Reprod Toxicol; 2014 Sep; 48():115-23. PubMed ID: 24859269
    [Abstract] [Full Text] [Related]

  • 10. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F, Rohatagi S, Pino M, DeLise B, Zhang J, Nguyen M, Guittin P, Barbellion S, Brunel P, Hofmann T, Schmidt J, Wong M, Lockey P, Lerman S, Clark R.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo reproduction toxicology of 12 monoaminergic reuptake inhibitors: possible mechanisms of infrequent cardiovascular anomalies.
    Sloot WN, Bowden HC, Yih TD.
    Reprod Toxicol; 2009 Sep; 28(2):270-82. PubMed ID: 19383541
    [Abstract] [Full Text] [Related]

  • 12. Physiologically based pharmacokinetics of methoxyacetic acid: dose-effect considerations in C57BL/6 mice.
    O'Flaherty EJ, Nau H, McCandless D, Beliles RP, Schreiner CM, Scott WJ.
    Teratology; 1995 Aug; 52(2):78-89. PubMed ID: 8588185
    [Abstract] [Full Text] [Related]

  • 13. Common nature in the effects of thalidomide on embryo-fetal development in Kbl:JW and Kbl:NZW rabbits.
    Kawamura Y, Shirotsuka Y, Awatsuji H, Matsumoto K, Sato K.
    Congenit Anom (Kyoto); 2014 Feb; 54(1):41-53. PubMed ID: 24206199
    [Abstract] [Full Text] [Related]

  • 14. Species-specificity of ethylene glycol-induced developmental toxicity: toxicokinetic and whole embryo culture studies in the rabbit.
    Carney EW, Tornesi B, Markham DA, Rasoulpour RJ, Moore N.
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):573-81. PubMed ID: 19025792
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the developmental toxicity of lenalidomide in rabbits.
    Christian MS, Laskin OL, Sharper V, Hoberman A, Stirling DI, Latriano L.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):188-207. PubMed ID: 17570132
    [Abstract] [Full Text] [Related]

  • 16. A developmental model for thalidomide defects.
    Tabin CJ.
    Nature; 1998 Nov 26; 396(6709):322-3. PubMed ID: 9845068
    [No Abstract] [Full Text] [Related]

  • 17. Prenatal developmental toxicity of decabromodiphenyl ethane in the rat and rabbit.
    Hardy ML, Mercieca MD, Rodwell DE, Stedeford T.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Apr 26; 89(2):139-46. PubMed ID: 20437473
    [Abstract] [Full Text] [Related]

  • 18. Embryotoxicant-specific transcriptomic responses in rat postimplantation whole-embryo culture.
    Robinson JF, van Beelen VA, Verhoef A, Renkens MF, Luijten M, van Herwijnen MH, Westerman A, Pennings JL, Piersma AH.
    Toxicol Sci; 2010 Dec 26; 118(2):675-85. PubMed ID: 20864626
    [Abstract] [Full Text] [Related]

  • 19. [Embryotoxic properties of drugs].
    Smol'nikova NM, Golovanova IV, Proĭnova VA, Skosyreva AM, Strekalova SN.
    Farmakol Toksikol; 1982 Dec 26; 45(4):115-9. PubMed ID: 6751867
    [No Abstract] [Full Text] [Related]

  • 20. A new mammalian model system for thalidomide teratogenesis: Monodelphis domestica.
    Sorensen D, Sackett A, Urban DJ, Maier J, Vargesson N, Sears KE.
    Reprod Toxicol; 2017 Jun 26; 70():126-132. PubMed ID: 28130151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.